Oncotarget

Research Papers:

Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemia

Sandrine Poglio, Daniel Lewandowski, Julien Calvo, Aurélie Caye, Audrey Gros, Elodie Laharanne, Thierry Leblanc, Judith Landman-Parker, André Baruchel, Jean Soulier, Paola Ballerini, Emmanuelle Clappier and Françoise Pflumio _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:41599-41611. https://doi.org/10.18632/oncotarget.9313

Metrics: PDF 1014 views  |   HTML 1331 views  |   ?  


Abstract

Sandrine Poglio1,2,3,4, Daniel Lewandowski2,3,4,5, Julien Calvo1,2,3,4, Aurélie Caye6,7, Audrey Gros8,9, Elodie Laharanne8,9, Thierry Leblanc10, Judith Landman-Parker11, André Baruchel10, Jean Soulier6,12,13, Paola Ballerini1,2,3,4,11, Emmanuelle Clappier6,12,13, Françoise Pflumio1,2,3,4

1Commissariat à l’Energie Atomique et aux Energies Alternatives (CEA), DSV-IRCM-SCSR-LSHL, UMR 967, Fontenay-aux-Roses, France

2INSERM, U967, Fontenay-aux-Roses, France

3Université Paris Diderot, Sorbonne Paris Cité, UMR 967, Fontenay-aux-Roses, France

4Université Paris-Sud, UMR 967, Fontenay-aux-Roses, France

5CEA, DSV-IRCM-SCSR-LRTS, UMR 967, Fontenay-aux-Roses, France

6Université Paris Diderot, Paris, France

7Assistance Publique-Hôpitaux de Paris (AP-HP), Département de Génétique, UF de Génétique Moléculaire, Hôpital Robert Debré Paris, France

8INSERM, UMR1053 Bordeaux Research in Translational Oncology (BaRITOn), Bordeaux, France

9Université de Bordeaux, Bordeaux, France

10AP-HP, Service d’hématologie Pédiatrique, Hôpital Robert Debré, Paris, France

11AP-HP, Service d’hématologie Pédiatrique, Hôpital Armand Trousseau, Paris, France

12AP-HP, Laboratoire d’Hématologie, Hôpital Saint-Louis, Paris, France

13Team Genome and Cancer, U944 INSERM, Paris, France

Correspondence to:

Françoise Pflumio, email: francoise.pflumio@cea.fr

Sandrine Poglio, email: sandrine.poglio@u-bordeaux.fr

Keywords: T-ALL, leukemia initiating cells, clonal selection, CD34, xenograft

Received: June 29, 2015    Accepted: April 22, 2016    Published: May 12, 2016

ABSTRACT

T cell acute lymphoblastic leukemia (T-ALL) develops through accumulation of multiple genomic alterations within T-cell progenitors resulting in clonal heterogeneity among leukemic cells. Human T-ALL xeno-transplantation in immunodeficient mice is a gold standard approach to study leukemia biology and we recently uncovered that the leukemia development is more or less rapid depending on T-ALL sample. The resulting human leukemia may arise through genetic selection and we previously showed that human T-ALL development in immune-deficient mice is significantly enhanced upon CD7+/CD34+ leukemic cell transplantations. Here we investigated the genetic characteristics of CD7+/CD34+ and CD7+/CD34 cells from newly diagnosed human T-ALL and correlated it to the speed of leukemia development. We observed that CD7+/CD34+ or CD7+/CD34 T-ALL cells that promote leukemia within a short-time period are genetically similar, as well as xenograft-derived leukemia resulting from both cell fractions. In the case of delayed T-ALL growth CD7+/CD34+ or CD7+/CD34 cells were either genetically diverse, the resulting xenograft leukemia arising from different but branched subclones present in the original sample, or similar, indicating decreased fitness to mouse micro-environment. Altogether, our work provides new information relating the speed of leukemia development in xenografts to the genetic diversity of T-ALL cell compartments.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 9313